-
Most Recent

Cannabis Stocks
Cannabis is a psychoactive drug that is a part of the Cannabacaee plant family. In the past few years, acceptance of the drug has risen dramatically. Industry leaders, like Canopy Growth and Curaleaf, are quickly establishing the framework for legal cannabis sales. THC is believed to be the component in cannabis that creates the psychoactive effect, which can be used to treat depression, anxiety, sleeping problems, and a wide range of other issues.

3 Cannabis Stocks That Can Be Massive Wealth Creators by 2030
These are the cannabis stocks to buy as they represent companies with improving fundamentals and accelerated growth outlook.

7 Growth Stocks That Could 7X in the Next 7 Years
Investors consider these growth stocks to buy since they represent companies with good fundamentals and a positive industry outlook.

3 Cannabis Stocks to Sell in August Before They Crash & Burn
Marijuana could be a major industry in the U.S. if it was legalized but these cannabis stocks to sell have other problems to contend with.
Recent Cannabis Stocks Articles
Why Aphria Stock Will Be the Next Billion-Dollar Pot Behemoth
APHA has big plans and the numbers to back them up, which will help make Aphria stock the next big thing in pot stocks.
3 Hot Investing Trends: Next Steps and Big Opportunities
The profit potential for investors who get in early on the marijuana, transportation and 5G trends is massive. Here's a quick update on each theme.
Here’s Why Tilray Stock Is a High-Risk, High-Reward Situation
TLRY stock has been, still is, and will remain the most volatile pot stock in the market.
A New Way to Make Money in Marijuana Stocks
Analysts who focus on only one way of investing in marijuana stocks are missing the forest for the trees.
A Historic Day in Congress Puts This HUGE Money-Making Theme One Step Closer
It’s only a matter of time before marijuana legalization hits more states -- and with federal government out of the way, the entire U.S.
Marijuana Legalization Inches Closer With Historic Reform Hearing
Marijuana legalization 2019 efforts are moving ahead following a reform hearing on Wednesday concerning the drug and we have the highlights.
Global Legalization Will Determine the Fate of Aurora Stock
Aurora's broad reach will make it a leader if global legalization accelerates -- and a loser if it doesn't.
Tilray Prepares a Second Act That Could Rekindle TLRY Stock
Tilray stock has conspicuously taken a beating relative to the major cannabis players, but the underlying company's presence in the U.K. could change the narrative.
3 Reasons Cronos Group Stock Deserves A Buy Rating
Cronos currently has a market cap of $5.4 billion. In the first quarter, it closed the Altria investment. At the end of March, it had $1.8 billion in cash on the balance sheet. CRON stock is trading at less than 3x cash.
Can Vaping Growth Help Investors Extract More Value From Aphria Stock?
Aphria's interim CEO recognizes that vape products are growing while dried flower is slowing. That trend is one of the multiple catalysts likely to fuel APHA stock in the next year.
Aurora Cannabis Stock: Strong Potential, But This Isn’t the Time to Buy
Aurora Cannabis is making smarts moves globally, but the risks of oversupply and lack of strong American catalyst signal caution for investors.
Expect More Dips, Less Rips in Canopy Growth Stock
Canopy Growth (CGC) is poised to dominate the American cannabis market. But after a weak earnings report, its current sky-high valuation is in question.
KERN Stock: What Happened, and What’s Next
Akerna (KERN) caused quite a bit of excitement in the pot stock community last week. Its meteoric rise might have looked magical – or like a fluke. But, in fact, KERN stock’s success has been a long time coming.